SCHEMBL6439246

SCHEMBL6439246

Cc1nc2ccc(C(=O)Nc3ccc(NC(=O)c4cnccn4)cc3)cc2cc1N

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 14/20 0.56
NPC1 O15118 12/20 0.56
SMN1; SMN2 Q16637 6/20 0.56
MAPT P10636 5/20 0.52
USP2 O75604 2/20 0.52
KMT2A Q03164 4/20 0.50
MEN1 O00255 2/20 0.50
HPGD P15428 2/20 0.50
TP53 P04637 3/20 0.49
POLB P06746 1/20 0.48
CYP2C19 P33261 1/20 0.47
ALDH1A1 P00352 2/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
BRAF P15056 1/20 0.46
HDAC3 O15379 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC8 Q9BY41 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3241423 0.86 DNMT1 (0.51) RAB9ANPC1SMN1; SMN2MAPTKMT2A
SCHEMBL3238075 0.82 MMP9 (0.56) RAB9ANPC1SMN1; SMN2KMT2AMEN1
SCHEMBL6436345 0.80 SMN1; SMN2 (0.57) RAB9ANPC1SMN1; SMN2MAPTKMT2A
SCHEMBL6439243 0.75 RAB9A (0.51) RAB9ANPC1SMN1; SMN2MAPTUSP2
SCHEMBL7718028 0.73 NPC1 (0.72) RAB9ANPC1SMN1; SMN2MAPTUSP2
SCHEMBL18027795 0.73 NPC1 (1.00) RAB9ANPC1SMN1; SMN2MAPTUSP2
SCHEMBL3240104 0.70 MMP9 (0.56) SMN1; SMN2KMT2AMEN1
SCHEMBL5553523 0.70 NPC1 (0.51) RAB9ANPC1SMN1; SMN2MAPTUSP2
SCHEMBL12764166 0.70 RAB9A (1.00) RAB9ANPC1SMN1; SMN2MAPTUSP2
SCHEMBL27787262 0.69 RAB9A (0.63) RAB9ANPC1SMN1; SMN2MAPTUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1509516-A1 INHIBITORS OF THE GPIB -VWF INTERACTION, THEIR PREPARATION AND USE Aventis Pharma Deutschland GmbH (DE) 2005-03-02 EP disclosed
WO-2003104221-A1 INHIBITORS OF THE GPIB -VWF INTERACTION, THEIR PREPARATION AND USE AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-12-18 WO disclosed